New Pre-Clinical and Clinical Data on GeNO LLC's Nitric Oxide Delivery Systems to be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings
1/29/2013 9:24:25 AM
More...
|
GeNO LLC Announces Senior Management Appointments
12/19/2012 6:21:27 AM
More...
|
FDA Accepts GeNO LLC Filing of New Drug Application for GeNOsyl™ MVG-2000 Nitric Oxide Delivery System
11/13/2012 10:20:54 AM
More...
|
GeNO LLC Receives Four Additional Patents for Inhaled Nitric Oxide Delivery
8/21/2012 12:40:00 PM
More...
|
FDA Grants Orphan Drug Designation to GeNO LLC for Use of Inhaled Nitric Oxide in Treatment of Persistant Pulmonary Hypertension of the Newborn (PPHN)
8/14/2012 10:11:34 AM
More...
|
GeNO LLC Gets FDA OK for Nitric Oxide Delivery System
8/10/2012 7:17:25 AM
More...
|
GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery
7/31/2012 9:54:28 AM
More...
|
New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
4/19/2012 10:54:19 AM
More...
|
New Data on GeNO LLC Nitric Oxide Delivery System to be Presented at ISHLT Conference Next Week
4/11/2012 10:08:14 AM
More...
|
GeNO LLC Receives New Patent for Nitric Oxide Delivery Technology
1/31/2012 10:55:52 AM
More...
|
|